440679-63-0

Upstream product

• 2212-75-1 N₂-[(benzyloxy)carbonyl]-L-lysine 
• 100-52-7 benzaldehyde 

Downstream Products

• 171287-53-9 (S)-2-Benzyloxycarbonylamino-6-(hexadecanoyl-hydroxy-amino)-hexanoic acid methyl ester 
• 157505-72-1 (S)-2-Benzyloxycarbonylamino-6-hydroxyamino-hexanoic acid methyl ester 
• 945496-81-1 C₄₇H₈₂N₂O₇ 
• 945496-85-5 C₅₅H₇₉N₅O₁₁ 
• 945496-86-6 C₅₅H₇₉N₅O₁₁ 
• 1026961-63-6 C₄₅H₆₃N₃O₈ 
• 945496-83-3 C₄₆H₆₅N₃O₈ 
• 440679-64-1 ((S)-1-Hydroxy-2-oxo-azepan-3-yl)-carbamic acid benzyl ester 
• 210547-90-3 (S)-3-Amino-1-(tert-butyl-diphenyl-silanyloxy)-azepan-2-one 
• 171287-62-0 [(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-oxo-azepan-3-yl]-carbamic acid benzyl ester 
• 440679-67-4 [(S)-3-((S)-2-Acetylsulfanyl-3-phenyl-propionylamino)-2-oxo-azepan-1-yloxy]-acetic acid ethyl ester 
• 440679-76-5 (R)-2-[(Benzyloxy-formyl-amino)-methyl]-N-((S)-1-hydroxy-2-oxo-azepan-3-yl)-3-phenyl-propionamide 

Relevant academic research and scientific papers

β-Lactams in synthesis: short syntheses of cobactin analogs

Mycobactins facilitate assimilation of iron by mycobacteria. Synthetic analogs with structural variation of the cobactin component have potent anti-TB activity. A new method for the synthesis of cobactin analogs is presented. The key process involves sing

Synthesis and studies of catechol-containing mycobactin S and T analogs

The syntheses of catechol-containing mycobactin S and T analogs are described. These analogs incorporate a catechol-glycine moiety in place of the phenol-oxazoline of the naturally occurring mycobactins S and T. Studies indicated that the new siderophore

Synthesis and Biological Activity of Hydroxamic Acid-Derived Vasopeptidase Inhibitor Analogues

(Equation Presented) Syntheses of novel hydroxamic acid-derived azepinones containing pendant mercaptoacyl groups or formyl hydroxamates are described. These new analogues of therapeutically important ACE and NEP inhibitors include unprecedented changes a